- Atlas of End-Stage Renal Disease. Bethesda: National Institutes of Health, NIDDK; 2005. USRDS 2005 Annual Data Report.
- KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007 Feb; 49(2 Suppl 2):S12–154.
- Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011.
- Keen H. The Diabetes Control and Complications Trial (DCCT). Health Trends. 1994; 26(2):41–3.
- Schrier RW, Estacio RO, Mehler PS, Hiatt WR. Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial. Nat Clin Pract Nephrol. 2007 Aug; 3(8):428–38.
- Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The Collaborative Study Group. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med. 1993 Nov 11;329(20):1456–62.
- Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001 Sep 20; 345(12):851–60.
- Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001 Sep 20; 345(12):861–9.
- Jalal DI, Maahs DM, Hovind P, Nakagawa T. Uric acid as a mediator of diabetic nephropathy. Semin Nephrol. 2011 September ; 31(5): 459–465.
- Jalal DI, et al Serum Uric acid level predict the development of albuminuria over 6 years in patients with type I diabetes: findings from the Coronary Artery Clacification in Type I Diabetes Study, Nephropl Dial Transplant 2012; 25:1865-1869.
- Hovingd P, et al Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study, Diabetes 2009;58:1668-71.
- Ficociello LH, et al High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up. Diabetes Care 2010;33:1337-43.
- Goicoechia M et al, Effect of allopurinol in chronic kidney disease progression and cardiovascular risk, Clin J Am Soc Nephrol 5: 1388-1393, 2010.
- Siu Y-P, et al. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level, Am J Kidney Dis 47: 51-59, 2005.
- Wild S_et al_ Global Prevalence of Diabetes_Diabetes Care_Vol 27_number 5_1047_ 2004
- Alicic RZ_ diabetic Kidney Disease_ Clin J aM Soc Nephrol_ 12_2032_2017-2032.full